WechatIMG11.png
  • Home

  • Philosophy

  • People

    • Interns
  • Portfolio Companies

  • News and Events

  • Contact

  • More

    Use tab to navigate through the menu items.
    主页
    团队
    核心理念
    成功案例
    新闻动态
    联系我们
    最新资讯
    GrowthCap Top 25 Healthcare Investors - William Dai

    GrowthCap Top 25 Healthcare Investors - William Dai

    William Dai named one of GrowthCap's Top 25 Healthcare Investors of 2022

    William Dai named one of GrowthCap's Top 25 Healthcare Investors of 2022

    Apexigen to go public via SPAC merger

    Apexigen to go public via SPAC merger

    Huma.AI Series A & Product Update

    Huma.AI Series A & Product Update

    2022 SVB Report Results

    2022 SVB Report Results

    Robert Kamen joins ShangBay Capital as our newest Senior Advisor

    Robert Kamen joins ShangBay Capital as our newest Senior Advisor

    Contraline closes $10.7M Series A Financing Round

    Contraline closes $10.7M Series A Financing Round

    Tvardi Therapeutics among Fierce Biotech's "Fierce 15" of 2021

    Tvardi Therapeutics among Fierce Biotech's "Fierce 15" of 2021

    Devoro Medical Reaches Acquisition Agreement with Boston Scientific!

    Devoro Medical Reaches Acquisition Agreement with Boston Scientific!

    Laplace Interventional Announces $7.9 Million Series A for its Transcatheter Tricuspid Valve

    Laplace Interventional Announces $7.9 Million Series A for its Transcatheter Tricuspid Valve

    © 2021 ShangBay Capital. All Rights Reserved